UMIN000048902
Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Japan Clinical Oncology Group (JCOG)·Not Applicable·University Hospital Medical Information NetworkRecruitment Completed
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Japan Clinical Oncology Group (JCOG)
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Jun 03, 2022
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048902
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048902 through Pure Global AI's free database. This Not Applicable trial is sponsored by Japan Clinical Oncology Group (JCOG) and is currently Recruitment Completed. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.